Subtopic Deep Dive

BCOR Mutations in Ocular Disorders
Research Guide

Q: What defines BCOR mutations in ocular disorders?

Hemizygous loss-of-function mutations in BCOR cause OFCD and Lenz microphthalmia syndromes with microphthalmia and anterior segment dysgenesis (Ng et al., 2004).

Q: What methods identify BCOR mutations?

Next-generation sequencing screens for hemizygous variants in sporadic cataracts and syndromic microphthalmia (Ma et al., 2015); Sanger sequencing confirms in OFCD/Lenz cohorts (Hilton et al., 2009).

Q: What are key papers on BCOR ocular mutations?

Ng et al. (2004, 319 citations) defines mutation classes in OFCD/Lenz; Hilton et al. (2009, 107 citations) extends to ocular anomalies with cardiac defects.

Q: What open problems exist in BCOR ocular research?

Functional validation of mutations in human models lags mouse expression studies (Wamstad and Bardwell, 2007); therapy targets for variable expressivity remain undeveloped (Harding and Moosajee, 2019).

What is BCOR Mutations in Ocular Disorders?

BCOR mutations cause hemizygous loss-of-function alterations leading to oculofaciocardiodental (OFCD) syndrome and Lenz microphthalmia syndrome with complex microphthalmia and anterior segment dysgenesis.

Sequencing studies identify distinct BCOR mutation classes in OFCD and Lenz syndromes (Ng et al., 2004, 319 citations). BCOR analysis in patients confirms mutations in microphthalmia, mental retardation with ocular anomalies, and cardiac defects (Hilton et al., 2009, 107 citations). Expression studies in mouse models reveal BCOR's role in eye morphogenesis (Wamstad and Bardwell, 2007, 44 citations). Over 10 papers from 2004-2021 document these genetic links.

Curated Papers

Key Challenges

Why It Matters

BCOR mutations explain genetic etiology in congenital eye malformations like microphthalmia and coloboma, enabling precise diagnosis in syndromic cases (Ng et al., 2004; Hilton et al., 2009). Next-generation sequencing identifies BCOR variants alongside other genes in sporadic congenital cataracts with microphthalmia and anterior segment dysgenesis (Ma et al., 2015, 132 citations). Genetic testing improves management of anophthalmia and microphthalmia, guiding prosthetic fitting and multidisciplinary care (Ragge et al., 2007, 127 citations). These findings support targeted therapies for childhood visual impairment.

Key Research Challenges

Mutation Spectrum Variability

Distinct BCOR mutation classes differentiate OFCD from Lenz microphthalmia, complicating diagnosis (Ng et al., 2004). Sporadic cases show variable expressivity with cataracts and anterior segment dysgenesis (Ma et al., 2015). Comprehensive screening requires next-generation sequencing to capture hemizygous variants.

Phenotypic Overlap with Syndromes

BCOR mutations overlap with coloboma, anophthalmia, and multisystem defects, hindering isolation (Gregory-Evans et al., 2004; Hilton et al., 2009). Clinical utility testing in preschool children reveals BCOR alongside PAX6 and OTX2 variants (Lenassi et al., 2019). Differentiating requires integrated genetic and phenotypic analysis.

Model Organism Translation

Mouse Bcor expression patterns inform eye morphogenesis but translation to human phenotypes varies (Wamstad and Bardwell, 2007). Limited functional studies hinder therapy development for microphthalmia (Harding and Moosajee, 2019). Bridging requires advanced sequencing and expression validation.

Essential Papers

Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR

David Ng, Nalin Thakker, Connie M. Corcoran et al. · 2004 · Nature Genetics · 319 citations

Ocular coloboma: a reassessment in the age of molecular neuroscience

CY Gregory-Evans, Michael Williams, Stephanie Halford et al. · 2004 · Journal of Medical Genetics · 245 citations

Congenital colobomata of the eye are important causes of childhood visual impairment and blindness. Ocular coloboma can be seen in isolation and in an impressive number of multisystem syndromes, wh...

Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next‐Generation Sequencing

Alan Ma, John Grigg, Gladys Ho et al. · 2015 · Human Mutation · 132 citations

Congenital cataracts are a significant cause of lifelong visual loss. They may be isolated or associated with microcornea, microphthalmia, anterior segment dysgenesis (ASD) and glaucoma, and there ...

A practical guide to the management of anophthalmia and microphthalmia

Nicola Ragge, I D Subak-Sharpe, J. R. O. Collin · 2007 · Eye · 127 citations

BCOR analysis in patients with OFCD and Lenz microphthalmia syndromes, mental retardation with ocular anomalies, and cardiac laterality defects

Emma Hilton, Jennifer J. Johnston, Sandra Whalen et al. · 2009 · European Journal of Human Genetics · 107 citations

Ocular coloboma—a comprehensive review for the clinician

Lingam Gopal, Alok C. Sen, Vijaya Lingam et al. · 2021 · Eye · 105 citations

Novel mutations in PAX6, OTX2 and NDP in anophthalmia, microphthalmia and coloboma

Brett Deml, Linda M. Reis, Emmanuelle Lemyre et al. · 2015 · European Journal of Human Genetics · 85 citations

Reading Guide

Foundational Papers

Start with Ng et al. (2004, 319 citations) for core BCOR mutation classes in OFCD/Lenz; follow with Hilton et al. (2009, 107 citations) for expanded cohorts; Wamstad and Bardwell (2007, 44 citations) for mouse expression basis.

Recent Advances

Ma et al. (2015, 132 citations) for NGS in cataracts; Harding and Moosajee (2019, 81 citations) for molecular anophthalmia/microphthalmia synthesis; Lenassi et al. (2019, 62 citations) for clinical testing utility.

Core Methods

Next-generation sequencing for mutation detection (Ma et al., 2015); Sanger validation and BCOR analysis in patient cohorts (Hilton et al., 2009); in situ hybridization for mouse Bcor expression (Wamstad and Bardwell, 2007).

How PapersFlow Helps You Research BCOR Mutations in Ocular Disorders

Discover & Search

Research Agent uses searchPapers and citationGraph on 'BCOR mutations microphthalmia' to map 319-cited Ng et al. (2004) as hub, revealing Hilton et al. (2009) clusters. exaSearch uncovers sparse BCOR-ocular links; findSimilarPapers extends to Ma et al. (2015) for cataract overlaps.

Analyze & Verify

Analysis Agent applies readPaperContent to Ng et al. (2004) abstracts for mutation classes, then verifyResponse (CoVe) cross-checks claims against Hilton et al. (2009). runPythonAnalysis processes mutation frequency tables from Ma et al. (2015) with pandas for statistical enrichment (p<0.01); GRADE assigns high evidence to sequencing validations.

Synthesize & Write

Synthesis Agent detects gaps in BCOR functional studies post-Wamstad (2007), flagging therapy voids; Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Ng/Hilton, then latexCompile for publication-ready manuscripts. exportMermaid visualizes BCOR pathway diagrams from coloboma papers.

Use Cases

"Extract mutation frequencies from BCOR papers and plot prevalence in microphthalmia vs cataracts."

Research Agent → searchPapers('BCOR mutations ocular') → Analysis Agent → readPaperContent(Ng 2004, Ma 2015) → runPythonAnalysis(pandas groupby, matplotlib barplot) → CSV export of p-values and odds ratios.

"Compile LaTeX review of BCOR in OFCD and Lenz syndromes with citations."

Research Agent → citationGraph(Ng 2004) → Synthesis Agent → gap detection → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF) with figure tables.

"Find code for BCOR expression analysis in mouse eye models."

Research Agent → paperExtractUrls(Wamstad 2007) → Code Discovery → paperFindGithubRepo → githubRepoInspect(README, scripts) → runPythonAnalysis(reproduce expression plots).

Automated Workflows

Deep Research workflow scans 50+ BCOR/microphthalmia papers via searchPapers → citationGraph → structured report with GRADE scores on mutation evidence. DeepScan applies 7-step CoVe to verify coloboma links (Gregory-Evans 2004), checkpointing Hilton (2009) overlaps. Theorizer generates hypotheses on BCOR-PAX6 interactions from Ng/Ma papers.

Try Doxa for BCOR Mutations in Ocular Disorders Research

Frequently Asked Questions

What defines BCOR mutations in ocular disorders?

Hemizygous loss-of-function mutations in BCOR cause OFCD and Lenz microphthalmia syndromes with microphthalmia and anterior segment dysgenesis (Ng et al., 2004).

What methods identify BCOR mutations?

Next-generation sequencing screens for hemizygous variants in sporadic cataracts and syndromic microphthalmia (Ma et al., 2015); Sanger sequencing confirms in OFCD/Lenz cohorts (Hilton et al., 2009).

What are key papers on BCOR ocular mutations?

Ng et al. (2004, 319 citations) defines mutation classes in OFCD/Lenz; Hilton et al. (2009, 107 citations) extends to ocular anomalies with cardiac defects.

What open problems exist in BCOR ocular research?

Functional validation of mutations in human models lags mouse expression studies (Wamstad and Bardwell, 2007); therapy targets for variable expressivity remain undeveloped (Harding and Moosajee, 2019).